The anti-tumor effect of any chemotherapeutic drugs depends on two facets of cancer biology, first, the direct killing of tumor cells, and secondly is their ability to enhance the CD4+ and CD8+ tumor-infiltrating lymphocytes (TILs)-mediated immune response [50, 51]. Here, CD8A is linked to cancer.